CHELMSFORD, Mass., Feb. 11, 2020 /PRNewswire/ -- Brooks Automation,
Inc. (Nasdaq: BRKS) announced today that it has acquired RURO,
Inc., an informatics software company based in Frederick, Maryland. The total cash
purchase price of the acquisition was $15
million, subject to customary working capital and other
adjustments.
RURO provides cloud-based software solutions to manage
laboratory workflow and bio-sample data for a broad range of
customers in the biotech, healthcare, and pharmaceutical
sectors. Its customers include such names as MD Anderson,
Amgen, Exact Sciences, and the NIH. The addition of RURO's
capabilities and offerings will enable Brooks to offer enhanced
onsite and off-site management of biological sample inventories as
well as integration solutions to its customers for their
increasingly distributed workflow.
Steve Schwartz, president and CEO
commented, "In managing more than 50 million samples on behalf of
our customers, we have long been in a position to offer information
management solutions to many of our customers. We have worked
with RURO in recent years and found their solutions are very
effective at resolving the challenges of integrating
multi-laboratory workflows, managing distributed inventories, and
providing information security in a single solution. We are
in an ideal position to offer and implement these comprehensive
software solutions with increased value for our
customers."
The Company closed the acquisition earlier today and has aligned
the RURO management under the Brooks Life Sciences business in its
Sample Management operations. In the twelve months ended
December 31, 2019, RURO generated
approximately $5 million in revenue.
The Company expects the acquisition will be accretive to
non-GAAP earnings within the first year.
About Brooks Automation
Brooks is a leading
provider of life science and semiconductor manufacturing automation
solutions worldwide. The Company applies its automation and
cryogenics expertise to provide a full suite of reliable cold-chain
sample management solutions across life sciences in areas such as
drug development, clinical research and advanced cell
therapies. Brooks recently added global capability for gene
sequencing and gene synthesis services through its strategic
acquisition of GENEWIZ, expanding its sample-based services
offerings. With over 40 years as a partner to the
semiconductor manufacturing industry, Brooks is a provider of
industry-leading precision robotics, integrated automation systems
and services. Brooks is headquartered in Chelmsford, MA, with operations in
North America, Europe and Asia. For more information, visit
www.brooks.com.
About RURO, Inc.
RURO, Inc. was founded in
2006 and is headquartered in the heart of Maryland's biotechnology corridor. RURO
develops state of the art computer software for research,
biotechnological, pharmaceutical, healthcare and government
(homeland security) laboratories in the US and worldwide. RURO is a
web applications leader, combining world-class innovation and
industry experience so individuals can use computer software in new
ways and places. Their recent line of biological applications is
designed to increase the productivity of scientific, biotech and
pharmaceutical laboratories while maintaining the highest level of
security, versatility and knowledge.
"Safe Harbor Statement" under Section 21E of the Securities
Exchange Act of 1934
Some statements in this
release are forward-looking statements made under Section 21E of
the Securities Exchange Act of 1934. These statements are neither
promises nor guarantees but involve risks and uncertainties, both
known and unknown, that could cause Brooks' financial and business
results to differ materially from our expectations. They are based
on the facts known to management at the time they are made. These
forward-looking statements include but are not limited to
statements about the anticipated benefits of the acquisition of
RURO, Inc. and the expected future capabilities of the combined
companies. Factors that could cause results to differ from our
expectations include the following: potential difficulties with the
integration of the RURO, Inc. business into Brooks Life Sciences
and potential adverse reactions or changes to business
relationships resulting from Brooks' ownership of the RURO, Inc.
business. In addition, actual results are subject to other
risks that relate more broadly to Brooks' overall business,
including those that we have described in our filings with the
Securities and Exchange Commission, including but not limited to
our Annual Report on Form 10-K, current reports on Form 8-K and our
quarterly reports on Form 10-Q. As a result, we can provide no
assurance that our future results will not be materially different
from those projected. Brooks expressly disclaims any obligation or
undertaking to release publicly any updates or revisions to any
such statement to reflect any change in our expectations or any
change in events, conditions or circumstances on which any such
statement is based. Brooks undertakes no obligation to update the
information contained in this press release.
INVESTOR CONTACTS:
Mark Namaroff
Director, Investor Relations
Brooks Automation
978.262.2635
mark.namaroff@brooks.com
Sherry Dinsmore
Brooks Automation
978.262.2400
sherry.dinsmore@brooks.com
John Mills
Senior Managing Director
ICR, LLC
646.277.1254
John.mills@icrinc.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/brooks-acquires-laboratory-software-firm-ruro-inc-301003273.html
SOURCE Brooks Automation